• YD Bio: CEO and director Ethan Shen PhD reported a purchase of 18,378 ordinary shares at a weighted average price of USD 3.67.
• Directly held stake rose to 11,242,531 ordinary shares following the transaction.
• Form also lists 43,120,858 ordinary shares held indirectly.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. YD Bio Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-098030), on September 08, 2026, and is solely responsible for the information contained therein.